A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity

Journal of Neuroscience

Volumn 23, Issue 5, 2003, Pages 1697-1709

  Sung, Uhna ^a   Apparsundaram, Subramaniam ^a,d   Galli, Aurelio ^b   Kahlig, Kristopher M ^a,b   Savchenko, Valentina ^a   Schroeter, Sally ^a,e   Quick, Michael W ^c,f   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e PFIZER INC   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antidepressant; Catecholamine; Norepinephrine; Phorbol ester; Surface trafficking; Syntaxin 1A; Transport

Indexed keywords

ANTIDEPRESSANT AGENT; CATECHOLAMINE; NORADRENALIN TRANSPORTER; PHORBOL ESTER; PHOSPHOTRANSFERASE; RECEPTOR; SNARE PROTEIN; SYNTAXIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CATALYSIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SYNAPTIC TRANSMISSION;

EID: 0037335481     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-05-01697.2003     Document Type: Article

References (79)

1. Apparsundaram S, Galli A, DeFelice LJ, Hartzell HC, Blakely RD (1998a) Acute regulation of norepinephrine transport. I. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J Pharmacol Exp Ther 287:733-743.
2. Apparsundaram S, Schroeter S, Giovanetti E, Blakely RD (1998b) Acuteregulation of norepinephrine transport. II. PKC-modulated surface expression of human norepinephrine transporter proteins. J Pharmacol Exp Ther 287:744-751.
3. Apparsundaram S, Sung U, Price RD, Blakely RD (2001) Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J Pharmacol Exp Ther 299:666-677.
4. Arnsten AF (2001) Modulation of prefrontal cortical-striatal circuits: relevance to therapeutic treatments for Tourette syndrome and attention-deficit hyperactivity disorder. Adv Neurol 85:333-341.
5. Axelrod J, Kopin IJ (1969) The uptake, storage, release, and metabolism of noradrenaline in sympathetic nerves. Prog Brain Res 31:21-32.
6. Axelrod J, Whitby LG, Hertting G (1961) Effect of psychotropic drugs on the uptake of H3-norepinephrine by tissues. Science 133:383-384.
7. Barker EL, Blakely RD (1995) Norepinephrine and serotonin transporters: molecular targets of antidepressant drugs. In: Psychopharmacology: the fourth generation of progress (Bloom FE, Kupfer DJ, eds), pp 321-333. New York: Raven.
8. Barker EL, Moore KR, Rakhshan F, Blakely RD (1999) Transmembrane domain I contributes to permeation pathways for serotonin and ions in the serotonin transporter. J Neurosci 19:4705-4717.
9. Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD (2000) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20:7571-7578.
10. Bauman PA, Blakely RD (2002) Determinants within the C terminus of the human norepinephrine transporter dictate trafficking, stability, and activity. Arch Biochem Biophys 404:80-91.
11. Beckman ML, Bernstein EM, Quick MW (1998) Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A. J Neurosci 18:6103-6112.
12. Beckman ML, Bernstein EM, Quick MW (1999) Multiple G-protein- coupled receptors initiate protein kinase C redistribution of GABA transporters in hippocampal neurons. J Neurosci 19:RC9(1-6).
13. -)-coupled γ-aminobutyric acid transporter from rat brain, impairs net flux but not exchange. J Biol Chem 275:34106-34113.
14. Bennett MK, Garcia-Arraras JE, Elferink LA, Peterson K, Fleming AM, Hazuka CD, Scheller RH (1993) The syntaxin family of vesicular transport receptors. Cell 74:863-873.
15. Betz A, Ashery U, Rickmann M, Augustin I, Neher E, Sudhof TC, Rettig J, Brose N (1998) Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release. Neuron 21:123-136.
16. Bezprozvanny I, Scheller RH, Tsien RW (1995) Functional impact of syntaxin on gating of N-type and Q-type calcium channels. Nature 378:623-626.
17. Bittner MA, Bennett MK, Holz RW (1996) Evidence that syntaxin 1A is involved in storage in the secretory pathway. J Biol Chem 271:11214-11221.
18. Blakely RD, Bauman AL (2000) Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol 10:328-336.
19. Bohm M, La Rosee K, Schwinger RHG, Erdmann E (1995) Evidence for reduction of norepinephrine uptake sites in the failing human heart. J Am Coll Cardiol 25:146-153.
20. Brain KL, Cottee LJ, Bennett MR (1997) Varicosities of single sympathetic nerve terminals possess syntaxin zones and different synaptotagmin N terminus labeling following stimulation. J Neurocytol 26:491-500.
21. Burrows GD, Maguire KP, Norman TR (1998) Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine: a review. J Clin Psychiatry 59:4-7.
22. Chen NH, Reith ME (1994) Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J Neurochem 63:1701-1713.
23. Deken SL, Beckman ML, Boos L, Quick MW (2000) Transport rates of GABA transporters: regulation by the N-terminal domain and syntaxin 1A. Nat Neurosci 3:998-1003.
24. Deken SL, Beckman ML, Quick MW (2001) PICKing on transporters. Trends Neurosci 24:623-625.
25. Delgado PL, Moreno FA (2000) Role of norepinephrine in depression. J Clin Psychiatry 61:5-12.
26. Esler M, Jackman G, Bobik A, Leonard P, Kelleher D, Skews H, Jennings G, KornerP (1981) Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension 3:149-156.
27. + channel with syntaxin 1A: functional impact on channel gating. J Neurosci 21:1964-1974.
28. Foote SL, Bloom FE, Aston-Jones G (1983) Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844-914.
29. Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD (1995) Sodium-dependent norepinephrine-induced currents in norepinephrine transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198:2197-2212.
30. Galli A, Blakely RD, DeFelice LJ (1998) Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake. Proc Natl Acad Sci USA 95:13260-13265.
31. Geerlings A, Lopez-Corcuera B, Aragon C (2000) Characterization of the interactions between the glycine transporters GLYT1 and GLYT2 and the SNARE protein syntaxin 1A. FEBS Lett 470:51-54.
32. Geerlings A, Nunez E, Lopez-Corcuera B, Aragon C (2001) Calcium- and syntaxin 1-mediated trafficking of the neural glycine transporter GLYT2. J Biol Chem 276:17584-17590.
33. Gorman JM, Sullivan G (2000) Noradrenergic approaches to antidepressant therapy. J Clin Psychiatry 61:13-16.
34. Graefe KH, Bönisch H (1988) The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurons. In: Handbook of experimental pharmacology, Vol 90, Catecholamine, Pt I (Trebdelenburg U, Weiner N, eds), pp 193-245. Heidelberg: Springer.
35. Haase J, Killian AM, Magnani F, Williams C (2001) Regulation of the serotonin transporter by interacting proteins. Biochem Soc Trans 29:722-728.
36. Hadley D, Hoff M, Holik J, Reimherr F, Wender P, Coon H, Byerley W (1995) Manic depression and the norepinephrine transporter gene. Hum Hered 45:165-168.
37. Hata Y, Slaughter CA, Sudhof TC (1993) Synaptic vesicle fusion complex contains UNC-18 homologue bound to syntaxin. Nature 366:347-351.
38. 3H-norepinephrine. J Pharmacol Exp Ther 134:146-153.
39. Iversen LL (1965) Inhibition of noradrenaline uptake by drugs. J Pharm Pharmacol 17:62-64.
40. Iversen LL (1971) Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571-591.
41. Jackson M, Song W, Liu MY, Jin L, Dykes-Hoberg M, Lin CI, Bowers WJ, Federoff HJ, Sternweis PC, Rothstein JD (2001) Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature 410:89-93.
42. Jahn R, Sudhof TC (1999) Membrane fusion and exocytosis. Annu Rev Biochem 68:863-911.
43. Ji J, Tsuk S, Salapatek AM, Huang X, Chikvashvili D, Pasyk EA, Kang Y, Sheu L, Tsushima R, Diamant N, Trimble WS, Lotan I, Gaisano HY (2002) The 25 kDa synaptosome-associated protein (SNAP-25) binds and inhibits delayed rectifier potassium channels in secretory cells. J Biol Chem 277:20195-20204.
44. Kippenberger AG, Palmer DJ, Comer AM, Lipski J, Burton LD, Christie DL (1999) Localization of the noradrenaline transporter in rat adrenal medulla and PC12 cells: evidence for its association with secretory granules in PC12 cells. J Neurochem 73:1024-1032.
45. Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, Dilley G, Ordway GA (1997) Reduced levels of norepinephrine transporters in the locus ceruleus in major depression. J Neurosci 17:8451-8458.
46. Lee FJ, Liu F, Pristupa ZB, Niznik HB (2001) Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis. FASEB J 15:916-926.
47. Liang C, Fan THM, Sullebarger JT, Sakamoto S (1989) Decreased adrenergic neuronal uptake activity in experimental right heart failure. J Clin Invest 84:1267-1275.
48. Mager S, Kleinberger-Doron N, Keshet GI, Davidson N, Kanner BI, Lester HA (1996) Ion binding and permeation at the GABA transporter GAT1. J Neurosci 16:5405-5414.
49. McNew JA, Weber T, Parlati F, Johnston RJ, Melia TJ, Sollner TH, Rothman JE (2000) Close is not enough: SNARE-dependent membrane fusion requires an active mechanism that transduces force to membrane anchors. J Cell Biol 150:105-117.
50. Melikian HE, Ramamoorthy S, Tate CG, Blakely RD (1996) Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. Mol Pharmacol 50:266-276.
51. Merlet P, Dubois-Rande JL, Adnot S, Bourguignon MH, Benvenuti C, Loisance D, Valette H, Castaigne A, Syrota A (1992) Myocardial β-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 19:10-16.
52. Miner LH, Schroeter S, Blakely RD, Sesack SR (2000) Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. J Comp Neurol 427:220-234.
53. Naren AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, Benos DJ, Quick MW, Kirk KL (1997) Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature 390:302-305.
54. Nirenberg MJ, Chan J, Pohorilee A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1997) The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907.
55. Pacholczyk T, Blakely RD, Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350:350-354.
56. Perego C, Vanoni C, Villa A, Longhi R, Kaech SM, Frohli E, Hajnal A, Kim SK, PietriniG (1999) PDZ-mediated interactions retain the epithelial GABA transporter on the basolateral surface ofpolarized epithelial cells. EMBO J 18:2384-2393.
57. Pevsner J, Hsu SC, Scheller RH (1994) n-Sec1: a neural-specific syntaxin-binding protein. Proc Natl Acad Sci USA 91:1445-1449.
58. Qi Y, Wang JKT, McMilian M, Chikaraishi DM (1997) Characterization of a CNS cell line, CAD, in which morphological differentiation is initiated by serum deprivation. J Neurosci 17:1217-1225.
59. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD (1997) Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17:45-47.
60. 3H]desipramine binding in the peripheral and central nervous system: a specific site associated with the neuronal uptake of noradrenaline. Eur J Pharmacol 78:345-351.
61. Ramamoorthy S, Blakely RD (1999) Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-766.
62. Ramsey IS, DeFelice LJ (2002) Serotonin transporter function and pharmacology are sensitive to expression level: evidence for an endogenous regulatory factor. J Biol Chem 277:14475-14482.
63. 2+ channels with the presynaptic proteins syntaxin and SNAP-25. Proc Natl Acad Sci USA 93:7363-7368.
64. Ritz MC, Cone EJ, Kuhar MJ (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine, and serotonin transporters: a structure-activity study. Life Sci 46:635-645.
65. Rowe J, Corradi N, Malosio ML, Taverna E, Halban P, Meldolesi J, Rosa P (1999) Blockade of membrane transport and disassembly of the Golgi complex by expression of syntaxin 1A in neurosecretion-incompetent cells: prevention by rbSEC1. J Cell Sci 112:1865-1877.
66. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA 97:6850-6855.
67. Saxena S, Quick MW, Tousson A, Oh Y, Warnock DG (1999) Interaction of syntaxins with the amiloride-sensitive epithelial sodium channel. J Biol Chem 274:20812-20817.
68. Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Physiol Rev 80:717-766.
69. Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509-522.
70. Schroeter S, Apparsundaram S, Wiley RG, Miner LH, Sesack SR, Blakely RD (2000) Immunolocalization of the cocaine- and antidepressant-sensitive L-norepinephrine transporter. J Comp Neurol 420:211-232.
71. Schwartz JW, Blakely RD, DeFelice LJ (2002) Binding and transport in norepinephrine transporters: real-time, spatially resolved analysis in single cells using a fluorescent substrate. J Biol Chem, in press.
72. Sesack SR, Snyder CL (1995) Cellular and subcellular localization of syntaxin-like immunoreactivity in the rat striatum and cortex. Neuroscience 67:993-1007.
73. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D (2000) Orthostatic intolerance and tachycardia associated with norepinephrine transporter deficiency. N Engl J Med 342:541-549.
74. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340:249-258.
75. Torres GE, Yao WD, Mohn RR, Quan H, Kim K, Levey AI, Staudinger J, Caron MG (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30:121-134.
76. Wall SC, Gu H, Rudnick G (1995) Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol Pharmacol 47:544-550.
77. Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM,CaronMG (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci 3:465-471.
78. 2+ channels in pancreatic β-cells. Proc Natl Acad Sci USA 96:10164-10169.
79. - dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92:21-55.